Douglas A. Jabs, M.D., M.B.A. is an internationally-recognized expert in the evaluation and management of patients with uveitis and related immune-mediated ocular disorders, particularly on the use of immunosuppression to treat severe ocular inflammatory diseases. Founder of the Division of Ocular Immunology and Uveitis at Wilmer, he now is the Director of the Center for Clinical Trials and Evidence Synthesis at the Johns Hopkins University Bloomberg School of Public Health. Dr. Jabs is rated as an Advanced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. His top areas of expertise are Uveitis, CMV Retinitis, Scleritis, Cataract Removal, and Trabeculectomy.

Bryn M. Burkholder, M.D., is an assistant professor of ophthalmology at the Wilmer Eye Institute and the Antoinette R. Schifanelli Rising Professor of Ophthalmology, specializing in ocular inflammatory and infectious diseases, cataract surgery and comprehensive ophthalmology. Dr. Burkholder earned her bachelor's degree from Duke University, where she majored in biology, and received her medical degree from the University of Pennsylvania. After completing an internship at the Albert Einstein Medical Center in Philadelphia, she moved to Baltimore for her residency in ophthalmology at the Wilmer Eye Institute. Dr. Burkholder remained at Wilmer for her fellowship training in uveitis before joining the faculty in July 2012. Dr. Burkholder is rated as an Experienced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. Her top areas of expertise are Uveitis, Scleritis, Neuroretinitis, Episcleritis, and Cataract Removal.

Meghan Berkenstock, M.D., is an associate professor of ophthalmology at the Johns Hopkins Wilmer Eye Institute. She specializes in ocular inflammatory and infectious diseases, cataract surgery, and comprehensive ophthalmology. Since joining the faculty of the Wilmer Eye Institute in 2016, she has established a research focus on risk reduction and quality assurance initiatives in the care of patients with uveitis. She has implemented several initiatives to improve laboratory monitoring and understanding barriers to care in patients on immunosuppressive medications. The bulk of her research focuses on identifying ocular adverse events (IRAE) associated with the use of immunotherapy agents in the treatment of systemic malignancies. She is a member and the only ophthalmologist on the National Comprehensive Cancer Network Panel on developing guidelines to treat IRAEs. Dr. Berkenstock is rated as an Experienced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. Her top areas of expertise are Scleritis, Episcleritis, Uveitis, Vitrectomy, and Cataract Removal.

Rachel Bishop, M.D., M.P.H., is an ophthalmologist specializing in comprehensive eye care at the Wilmer Eye Institute’s locations in Frederick and Bethesda, Maryland. Before studying medicine, Dr. Bishop was an officer in the U.S. Army, serving as a medical evacuation platoon leader and executive officer in South Korea and as a hospital administrator at Letterman Army Hospital in San Francisco. She then pursued her medical degree at the University of Pennsylvania and, as a medical officer in the Army, completed ophthalmology residency training at the Walter Reed Army Medical Center in Washington, D.C. Following her residency, Dr. Bishop served as chief of ophthalmology at the Darnall Army Medical Center at Fort Hood in Texas. There she performed refractive surgery for thousands of soldiers before their deployment to Iraq and Afghanistan, and provided eye care for active duty military personnel, their families and retirees. In 2006, Dr. Bishop transferred to the U.S. Public Health Service (USPHS) and joined the National Eye Institute (NEI), where as chief of the consult service, she cared for people participating in clinical trials throughout the many institutes and centers of the National Institutes of Health (NIH). In this role, Dr. Bishop monitored medication and treatment side effects, managed eye conditions related to NIH protocols, and provided comprehensive eye care for adults and children treated at NIH. As a key NEI spokesperson, Dr. Bishop promoted eye health through a variety of media outlets, including TV and radio, print, and internet forums, and she helped produce educational videos and print materials for NEI. Continuing a career-long interest in medical ethics, she served as a member of NIH’s clinical bioethics committee for 12 years. In her final year at NEI, she led a strategic planning panel focused on low vision solutions and quality of life. She is interested in international public health, health economics and optimizing access to eye care through technology. In 2019, Dr. Bishop retired from the USPHS, where she had been deputy commander of a 130-member rapid deployment force that provided medical care for people displaced during natural disasters. Videos Meet Dr. Rachel Bishop Recent News Articles and Media Coverage Army Veteran Bishop Reflects on Service, Johns Hopkins Medicine (11/02/2021). Dr. Bishop is rated as an Experienced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. Her top areas of expertise are Uveitis, Cogan-Reese Syndrome, Chandler's Syndrome, and Iridocorneal Endothelial Syndrome.

Sharon D. Solomon, M.D., is the Katharine M. Graham Professor of Ophthalmology at the Wilmer Eye Institute. A retina specialist and ophthalmologist, Dr. Solomon's clinical expertise includes medical and surgical treatment of age-related macular degeneration, diabetic retinopathy, epiretinal membranes, macular holes, and retinal tears and detachment. Dr. Solomon has a large national and international referral practice at Wilmer. Dr. Solomon has served as principal investigator at Wilmer on a number of NIH-sponsored clinical trials. She has numerous publications from her clinical trials involvement. Dr. Solomon received her bachelor's degree in biochemistry from Harvard University and her medical degree from the University of California, San Francisco. After her internship at Stanford, she returned to UCSF for her residency in ophthalmology. Dr. Solomon completed her surgical retina fellowship at the Wilmer Eye Institute prior to joining the faculty. Dr. Solomon is a member of the prestigious Miller-Coulson Academy of Clinical Excellence at Johns Hopkins. Dr. Solomon is rated as an Experienced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. Her top areas of expertise are Retinal Vein Occlusion, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Gyrate Atrophy of the Choroid and Retina, and Vitrectomy.

Allen O. Eghrari, M.D., M.P.H., is director of the Dana Center for Preventive Ophthalmology at the Wilmer Eye Institute and associate professor of ophthalmology at the Johns Hopkins University School of Medicine. He specializes in cornea, cataract and external eye diseases at the Wilmer Eye Institute's locations in Baltimore and Belcamp, Maryland. Dr. Eghrari treats a wide range of eye conditions, with special interest in Fuchs' dystrophy, cataract surgery, cornea transplantation including Descemet Membrane Endothelial Keratoplasty, and Ebola-associated eye disease. Dr. Eghrari received his M.D. degree from the Johns Hopkins University School of Medicine and M.P.H. from the Johns Hopkins Bloomberg School of Public Health. He completed both residency training in ophthalmology and subspecialty fellowship in cornea and cataract surgery at the Wilmer Eye Institute. Dr. Eghrari is a recipient of the Claes Dohlman Society Fellowship Award, the ARVO/Alcon Early Career Clinician-Scientist Award, and the Research to Prevent Blindness Special Scholar Award. Dr. Eghrari is rated as an Experienced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. His top areas of expertise are Fuchs Dystrophy, Macular Corneal Dystrophy Type 1, Cataract, Corneal Transplant, and Cataract Removal.

Jordan Heffez is an Ophthalmologist in Bethesda, Maryland. Dr. Heffez is rated as an Experienced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. His top areas of expertise are Late-Onset Retinal Degeneration, X-Linked Retinal Dysplasia, X-Linked Juvenile Retinoschisis, Age-Related Macular Degeneration (ARMD), and Vitrectomy.

Sidney Schechet is an Ophthalmologist in Baltimore, Maryland. Dr. Schechet is rated as an Experienced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, Retinal Detachment, and Vitrectomy. Dr. Schechet is currently accepting new patients.

Kenneth Taubenslag is an Ophthalmologist in Baltimore, Maryland. Dr. Taubenslag is rated as an Experienced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. His top areas of expertise are Endophthalmitis, Neuroretinitis, Uveitis, Trabeculectomy, and Vitrectomy. Dr. Taubenslag is currently accepting new patients.

Eric Fleischer is an Ophthalmologist in Riverdale, Maryland. Dr. Fleischer is rated as an Experienced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. His top areas of expertise are Glaucoma, Cataract, Uveitis, and Neuroretinitis.

Travis Peck is an Ophthalmologist in Salisbury, Maryland. Dr. Peck is rated as an Experienced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. His top areas of expertise are Retinal Detachment, Endophthalmitis, Hereditary Retinoblastoma, Vitrectomy, and Cataract Removal. Dr. Peck is currently accepting new patients.

Andrea Apolo is a primary care provider, practicing in Internal Medicine in Bethesda, Maryland. Dr. Apolo is rated as an Experienced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. Her top areas of expertise are Penile Cancer, Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, and Neuroendocrine Tumor.

Panos Christakis is an Ophthalmologist in Bethesda, Maryland. Dr. Christakis is rated as an Experienced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Neuroretinitis, Trabeculectomy, and Vitrectomy.